Argentina’s local crop biotechnology developments: why have they not reached the market yet?
Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early const...
| Main Authors: | , |
|---|---|
| Format: | Artículo |
| Language: | Inglés |
| Published: |
Frontiers Media
2021
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.12123/8705 https://www.frontiersin.org/articles/10.3389/fbioe.2020.00301/full https://doi.org/10.3389/fbioe.2020.00301 |
| _version_ | 1855484251681587200 |
|---|---|
| author | Lewi, Dalia Marcela Vicien, Carmen |
| author_browse | Lewi, Dalia Marcela Vicien, Carmen |
| author_facet | Lewi, Dalia Marcela Vicien, Carmen |
| author_sort | Lewi, Dalia Marcela |
| collection | INTA Digital |
| description | Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early constitution in 1991 of a sound genetically modified organisms biosafety regulatory system. The first commercial approvals began in 1996, and to date, 59 events have obtained permits to be placed on the market, however, only two have been developed locally by public-private partnerships. The transgenic events developed at public institutions pursue different objectives in diverse crops. However, once these events have been developed in laboratories, it is difficult to move toward a possible commercial approval. In this work, we analyze several reasons that could explain why local developments have not reached approvals for commercialization, highlighting aspects related to the lack of strategic vision in the institutions to focus resources on projects to develop biotechnological products. Although progress has been made in generating regulatory rules adapted to research institutes (such as the regulations for biosafety greenhouses and ways of presenting applications), researchers still do not conceive regulatory science as a discipline. They generally prefer not to be involved in the design of regulatory field trials or regulatory issues related to the evaluation of events. In that sense, some of the aspects considered a regulatory affairs platform for the public scientific system and the reinforcement of laboratories that perform tests required under the Argentine regulation. |
| format | Artículo |
| id | INTA8705 |
| institution | Instituto Nacional de Tecnología Agropecuaria (INTA -Argentina) |
| language | Inglés |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media |
| publisherStr | Frontiers Media |
| record_format | dspace |
| spelling | INTA87052021-02-22T11:33:23Z Argentina’s local crop biotechnology developments: why have they not reached the market yet? Lewi, Dalia Marcela Vicien, Carmen Argentina Organismos Modificados Genéticamente Bioseguridad Biotecnología Genetically Modified Organisms Biosafety Biotechnology Commercial Approval Local Development Aprobación Comercial Desarrollo Local Plant biotechnology in Argentina started at the end of the 1980s, leading to the development of numerous research groups in public institutions and, a decade later, to some local private initiatives. The numerous scientific and technological capacities existing in the country allowed the early constitution in 1991 of a sound genetically modified organisms biosafety regulatory system. The first commercial approvals began in 1996, and to date, 59 events have obtained permits to be placed on the market, however, only two have been developed locally by public-private partnerships. The transgenic events developed at public institutions pursue different objectives in diverse crops. However, once these events have been developed in laboratories, it is difficult to move toward a possible commercial approval. In this work, we analyze several reasons that could explain why local developments have not reached approvals for commercialization, highlighting aspects related to the lack of strategic vision in the institutions to focus resources on projects to develop biotechnological products. Although progress has been made in generating regulatory rules adapted to research institutes (such as the regulations for biosafety greenhouses and ways of presenting applications), researchers still do not conceive regulatory science as a discipline. They generally prefer not to be involved in the design of regulatory field trials or regulatory issues related to the evaluation of events. In that sense, some of the aspects considered a regulatory affairs platform for the public scientific system and the reinforcement of laboratories that perform tests required under the Argentine regulation. Instituto de Genética Fil: Lewi, Dalia Marcela. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Genética; Argentina Fil: Vicien, Carmen. Universidad de Buenos Aires. Facultad de Agronomía; Argentina 2021-02-22T11:27:01Z 2021-02-22T11:27:01Z 2020-04 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/8705 https://www.frontiersin.org/articles/10.3389/fbioe.2020.00301/full 2296-4185 https://doi.org/10.3389/fbioe.2020.00301 eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) application/pdf Frontiers Media Frontiers in Bioengineering and Biotechnology 8 : 301 (Abril 2020) |
| spellingShingle | Argentina Organismos Modificados Genéticamente Bioseguridad Biotecnología Genetically Modified Organisms Biosafety Biotechnology Commercial Approval Local Development Aprobación Comercial Desarrollo Local Lewi, Dalia Marcela Vicien, Carmen Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title | Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title_full | Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title_fullStr | Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title_full_unstemmed | Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title_short | Argentina’s local crop biotechnology developments: why have they not reached the market yet? |
| title_sort | argentina s local crop biotechnology developments why have they not reached the market yet |
| topic | Argentina Organismos Modificados Genéticamente Bioseguridad Biotecnología Genetically Modified Organisms Biosafety Biotechnology Commercial Approval Local Development Aprobación Comercial Desarrollo Local |
| url | http://hdl.handle.net/20.500.12123/8705 https://www.frontiersin.org/articles/10.3389/fbioe.2020.00301/full https://doi.org/10.3389/fbioe.2020.00301 |
| work_keys_str_mv | AT lewidaliamarcela argentinaslocalcropbiotechnologydevelopmentswhyhavetheynotreachedthemarketyet AT viciencarmen argentinaslocalcropbiotechnologydevelopmentswhyhavetheynotreachedthemarketyet |